Status:
UNKNOWN
Effects of Knee Injections on Patients With Knee Osteoarthritis
Lead Sponsor:
Taipei Medical University
Collaborating Sponsors:
Shin Kong Wu Ho-Su Memorial Hospital
Conditions:
Knee Osteoarthritis
Injection
Eligibility:
All Genders
40-85 years
Phase:
PHASE4
Brief Summary
Using a double-blind, randomized, placebo-controlled design to compare the immediate, short-term, and intermediate-term additional therapeutic effects of ultrasound-guided corticosteroid injection and...
Detailed Description
A total of 60 patients will be collected. The participants will be randomized into three groups, including the hyaluronic acid combined corticosteroid group, hyaluronic acid combined dextrose group, a...
Eligibility Criteria
Inclusion
- clinical diagnosis of knee osteoarthritis
- can walk for 15 meters
- Kellgren-Lawrence grade 2 or greater
- can follow up for 6 months
Exclusion
- Major diseases will affect balance, such as stroke
- infectious disease,
- rheumatoid arthritis,
- malignancy
- pregnancy or prepare to pregnant
- received knee injections in the past 6 months
- previous knee operation history
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05220527
Start Date
August 1 2020
End Date
July 31 2022
Last Update
February 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan, 111-01